We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
OmniAb Inc offers best-in-class therapeutic antibody discovery technologies. OmniAb Inc offers best-in-class therapeutic antibody discovery technologies.
単一ドメイン抗体（sdAb）を産生する遺伝子改変ニワトリが、完全ヒト型安定化sdAbを産生する2023年発表の新規トランスジェニックニワトリプラットフォームOmnidAb™の科学的基盤に （ビジネスワイヤ） -- Omni...
Engineered chickens producing single domain antibodies (sdAbs) provided the scientific foundation for OmnidAb™, the Company’s novel transgenic chicken platform launched in 2023 that generates...
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating at the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York...
Technical synergies between xPloration, OmniFlic®, OmniClic® and OmniDeep® enable new bispecific antibody discovery workflows for OmniAb’s partners OmniAb, Inc. (Nasdaq: OABI) today announced its...
Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three months ended March 31, 2024, and provided operating...
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five investor conferences during the month of May. RBC Capital Markets Global Healthcare Conference, May 14-15...
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Thursday, May 9, 2024 and will hold a...
Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and 12 months ended December 31, 2023, and provided...
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2023 after the close of the U.S. financial markets on Wednesday, March 20, 2024 and will...
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two upcoming investor conferences in March. TD Cowen 44th Annual Healthcare Conference, March 4-6, 2024, at...
| Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.32 | -7.86240786241 | 4.07 | 4.11 | 3.69 | 1097894 | 3.89518442 | CS |
| 4 | -0.75 | -16.6666666667 | 4.5 | 4.69 | 3.69 | 708411 | 4.1521364 | CS |
| 12 | -1.6 | -29.9065420561 | 5.35 | 5.45 | 3.69 | 606468 | 4.45556396 | CS |
| 26 | -2.42 | -39.2220421394 | 6.17 | 6.715 | 3.69 | 527100 | 5.05939422 | CS |
| 52 | -0.82 | -17.943107221 | 4.57 | 6.715 | 3.69 | 516365 | 5.10332922 | CS |
| 156 | -1.32 | -26.0355029586 | 5.07 | 6.715 | 1.91 | 728060 | 4.12605196 | CS |
| 260 | -1.32 | -26.0355029586 | 5.07 | 6.715 | 1.91 | 728060 | 4.12605196 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
